MDxHealth's H1 Revenues Double | GenomeWeb

NEW YORK (GenomeWeb News) – MDxHealth today said that its revenues for the first half of 2013 doubled year over year.

For the six months ended June 30, total revenues reached €3.0 ($4.0 million), up from €1.5 million in the first half of 2012. All revenues came from commercial operations as MDxHealth received no government grants, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.